Overall, IRF1 expression is beneficial for inhibiting the growth of GC cells through inducing tumor cell apoptosis, enhancing sensitivity to chemotherapy drugs, and suppressing the miR-18a/19a and Wnt/β-catenin pathways. The gene discussed is IRF1; the disease is gastric cancer.